Short-Term Outcomes in Patients Undergoing Virtual/Ghost Ileostomy or Defunctioning Ileostomy after Anterior Resection of the Rectum: A Meta-Analysis.
anterior rectal resection
colorectal cancer
ileostomy
outcomes
rectum
surgery
Journal
Journal of clinical medicine
ISSN: 2077-0383
Titre abrégé: J Clin Med
Pays: Switzerland
ID NLM: 101606588
Informations de publication
Date de publication:
23 May 2023
23 May 2023
Historique:
received:
05
04
2023
revised:
02
05
2023
accepted:
20
05
2023
medline:
10
6
2023
pubmed:
10
6
2023
entrez:
10
6
2023
Statut:
epublish
Résumé
Anterior rectal resection (ARR) represents one of the most frequently performed methods in colorectal surgery, mainly carried out for rectal cancer (RC) treatment. Defunctioning ileostomy (DI) has long been chosen as a method to "protect" colorectal or coloanal anastomosis after ARR. However, DI does not rule out risks of more or less serious complications. A proximal intra-abdominal closed-loop ileostomy, the so-called virtual/ghost ileostomy (VI/GI), could limit the number of DIs and the associated morbidity. We performed a systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyzes (PRISMA) guidelines. Meta-analysis was performed by use of RevMan [Computer program] Version 5.4. The five included comparative studies (VI/GI or DI) covering an approximately 20-year study period (2008-2021). All included studies were observational ones and originated from European countries. Meta-analysis indicated VI/GI as significantly associated with lower short-term morbidity rates related to VI/GI or DI after primary surgery (RR: 0.21, 95% CI: 0.07-0.64,
Sections du résumé
BACKGROUND AND OBJECTIVES
OBJECTIVE
Anterior rectal resection (ARR) represents one of the most frequently performed methods in colorectal surgery, mainly carried out for rectal cancer (RC) treatment. Defunctioning ileostomy (DI) has long been chosen as a method to "protect" colorectal or coloanal anastomosis after ARR. However, DI does not rule out risks of more or less serious complications. A proximal intra-abdominal closed-loop ileostomy, the so-called virtual/ghost ileostomy (VI/GI), could limit the number of DIs and the associated morbidity.
MATERIALS AND METHODS
METHODS
We performed a systematic review following the Preferred Reporting Items for Systematic Reviews and Meta-Analyzes (PRISMA) guidelines. Meta-analysis was performed by use of RevMan [Computer program] Version 5.4.
RESULTS
RESULTS
The five included comparative studies (VI/GI or DI) covering an approximately 20-year study period (2008-2021). All included studies were observational ones and originated from European countries. Meta-analysis indicated VI/GI as significantly associated with lower short-term morbidity rates related to VI/GI or DI after primary surgery (RR: 0.21, 95% CI: 0.07-0.64,
Identifiants
pubmed: 37297802
pii: jcm12113607
doi: 10.3390/jcm12113607
pmc: PMC10253561
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Références
Eur J Surg Oncol. 2021 Jul;47(7):1514-1525
pubmed: 33622575
J Surg Res. 2011 Mar;166(1):e27-34
pubmed: 21195424
Tech Coloproctol. 2021 Jul;25(7):751-760
pubmed: 33792822
Aust N Z J Surg. 1978 Aug;48(4):444-7
pubmed: 282884
Surg Today. 2019 Feb;49(2):108-117
pubmed: 30151626
Tech Coloproctol. 2020 Jan;24(1):23-31
pubmed: 31820192
Tech Coloproctol. 2022 May;26(5):333-349
pubmed: 35192122
Front Nutr. 2022 Apr 22;9:842198
pubmed: 35529469
Ann Surg. 2015 Aug;262(2):321-30
pubmed: 25361221
Ann Intern Med. 2009 Aug 18;151(4):264-9, W64
pubmed: 19622511
Colorectal Dis. 2021 Jul;23(7):1721-1732
pubmed: 33783976
Tech Coloproctol. 2019 Jul;23(7):649-663
pubmed: 31240416
Clin Colon Rectal Surg. 2019 May;32(3):171-175
pubmed: 31061646
Int J Colorectal Dis. 2021 Mar;36(3):445-455
pubmed: 33064212
Anticancer Res. 2019 Jun;39(6):2975-2983
pubmed: 31177138
Int J Gynecol Cancer. 2019 Sep;29(7):1170-1176
pubmed: 31296558
Langenbecks Arch Surg. 2021 Mar;406(2):339-347
pubmed: 33537875
Surg Endosc. 2013 Oct;27(10):3877-82
pubmed: 23708715
BMJ. 2016 Oct 12;355:i4919
pubmed: 27733354
Surg Innov. 2023 Apr 4;:15533506231169066
pubmed: 37013791
Hepatogastroenterology. 2011 Sep-Oct;58(110-111):1479-81
pubmed: 21940315
Langenbecks Arch Surg. 2011 Oct;396(7):997-1007
pubmed: 21479620
J Surg Res. 2017 Apr;210:204-212
pubmed: 28457330
In Vivo. 2022 May-Jun;36(3):1290-1296
pubmed: 35478159
BMJ. 2019 Aug 28;366:l4898
pubmed: 31462531
Ann Surg. 1948 Sep;128(3):425-42
pubmed: 17859211
J Gastrointest Surg. 2022 Nov;26(11):2368-2379
pubmed: 35915378
J Clin Med. 2019 Sep 12;8(9):
pubmed: 31547283
Arch Surg. 1975 Sep;110(9):1079-82
pubmed: 1098615
World J Surg Oncol. 2021 Nov 4;19(1):318
pubmed: 34732226
Gastroenterol Res Pract. 2020 Jan 3;2020:9057963
pubmed: 32411206
Br J Surg. 2014 Mar;101(4):424-32; discussion 432
pubmed: 24536013
Diagnostics (Basel). 2021 Dec 17;11(12):
pubmed: 34943616
Surg Today. 2010 Jun;40(6):501-6
pubmed: 20496130
Cir Esp (Engl Ed). 2023 Jan;101(1):3-11
pubmed: 35882311
Surgery. 2010 Mar;147(3):339-51
pubmed: 20004450
J Gastrointest Oncol. 2019 Apr;10(2):179-187
pubmed: 31032083
Langenbecks Arch Surg. 2019 Mar;404(2):129-139
pubmed: 30747281
Hepatogastroenterology. 2007 Sep;54(78):1676-8
pubmed: 18019692
J Visc Surg. 2015 Feb;152(1):5-10
pubmed: 25577712
Surg Oncol. 2022 Mar;40:101708
pubmed: 35092916
Minim Invasive Ther Allied Technol. 2016 Oct;25(5):226-33
pubmed: 27415777